Reference
Ma Y, et al. Renal safety of zoledronic acid in patients with osteoporosis: a retrospective study. Endocrine : 16 Nov 2023. Available from: URL: https://doi.org/10.1007/s12020-023-03567-5
Rights and permissions
About this article
Cite this article
Zoledronic acid for osteoporosis: risk of renal impairment. Reactions Weekly 1984, 12 (2023). https://doi.org/10.1007/s40278-023-50243-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-50243-x